Dexcom Announces FDA Clearance of New Dexcom G6 Pro CGM

Posted in Medical Device

October 08, 2019 • 2 min read

​Dexcom, Inc. (NASDAQ:DXCM) announced today the U.S. Food and Drug Administration (FDA) has cleared the Dexcom G6 Pro Continuous Glucose Monitoring (CGM) System for healthcare professionals to use with their patients, ages two years and up....

Intact Vascular Announces Positive One-Year Data from TOBA III Clinical Trial

Posted in Medical Device

September 30, 2019 • 2 min read

​Intact Vascular, Inc., a developer of medical devices for minimally invasive peripheral vascular procedures, today announced the positive one-year results of its Tack Optimized Balloon Angioplasty (TOBA) III clinical trial, successfully achieving both primary and secondary endpoints. Marianne Brodmann, M.D., Head of the Clinical Division of Angiology...